Is Ketamine FDA Approved?

Ketamine itself is not FDA-approved for the treatment of depression or other psychiatric conditions. However, a related medication called esketamine, a nasal spray marketed under the brand name Spravato, has been FDA-approved for treatment-resistant depression and major depressive disorder with acute suicidal ideation or behavior.

Ketamine is approved by the FDA as an anesthetic, and its off-label use for psychiatric conditions is based on emerging evidence and clinical practice. The benefits of Ketamine have been well documented and studied on a large scale, most notably under a federal funded study through the National Institute of Health (NIH) in 2006 (view study).

We are committed to patient safety, which is why we tailor every treatment plan to individual needs. Click the button below and receive a customized ketamine treatment plan within 2 days.